澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

DIMERIX LTD

0.440

-0.005-1.12%

成交量：51.21万

成交额：22.91万

市值：2.64亿

市盈率：-18.61

高：0.460

开：0.445

低：0.440

收：0.445

52周最高：0.785

52周最低：0.340

股本：6.00亿

流通股本：4.68亿

量比：0.94

换手率：0.11%

股息：- -

股息率：- -

每股收益(TTM):-0.024

每股收益(LYR):-0.024

净资产收益率：-83.97%

总资产收益率：-32.13%

市净率：19.74

市盈率(LYR):-18.61

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

DIMERIX LTD

交易所：

ASX

成立时间：

- -

员工人数：

- -

公司地址：

425 Smith Street,Fitzroy,Victoria,Australia

官网：

http://dimerix.com

邮编：

3065

电话：

传真：

61 8 9388 8256

简介：

Dimerix Limited, a clinical stage biotechnology company, develops and commercializes new therapies in the area of unmet medical needs. Its lead product candidate is DMX-200, which is in Phase II clinical trial for the treatment of diabetic kidney diseases and focal segmental glomerulosclerosis. The company is headquartered in Fitzroy, Australia.

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠： 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠： 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/DXB.AU/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"DXB.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"DXB.AU\",,,,,undefined,":{"symbol":"DXB.AU","market":"AU","secType":"STK","nameCN":"DIMERIX LTD","latestPrice":0.44,"timestamp":1771996320000,"preClose":0.445,"halted":0,"volume":512148,"delay":0,"changeRate":-0.011235955056179785,"nameEN":"DIMERIX LTD","floatShares":467696880,"shares":600396776,"eps":-0.023645,"marketStatus":"已收盘","change":-0.005,"latestTime":"02-25 16:12:00 AEDT","open":0.445,"high":0.46,"low":0.44,"amount":229100,"amplitude":0.044944,"askPrice":0.475,"askSize":48128,"bidPrice":0.44,"bidSize":17193,"shortable":3,"etf":0,"ttmEps":-0.023645,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":0,"beginTime":1772060400000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.445,"openAndCloseTimeList":[[1771974000000,1771995600000]],"volumeRatio":0.942114,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"DXB.AU\",,,,,undefined,":{"symbol":"DXB.AU","floatShares":467696880,"roa":"-32.13%","roe":"-83.97%","lyrEps":-0.023645,"volumeRatio":0.942114,"shares":600396776,"dividePrice":0,"high":0.46,"amplitude":0.044944,"preClose":0.445,"low":0.44,"week52Low":0.34,"pbRate":"19.74","psRate":"47.29","week52High":0.785,"institutionHeld":0,"latestPrice":0.44,"committee":-0.473584,"eps":-0.023645,"divideRate":0,"volume":512148,"delay":0,"ttmEps":-0.023645,"open":0.445,"prevYearClose":0.55,"prevWeekClose":0.475,"prevMonthClose":0.505,"prevQuarterClose":0.55,"fiveDayClose":0.475,"twentyDayClose":0.525,"sixtyDayClose":0.495,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DXB.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DXB.AU\",market:\"AU\",,,undefined,":[],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":23928564,"address":"425 Smith Street,Fitzroy,Victoria,Australia","zipCode":"3065","officePhone":"1300 813 321","officeFax":"61 8 9388 8256"},"stockCompanyDetail":{"websiteUrl":"http://dimerix.com","stockEarnings":[{"period":"1week","weight":-0.0729},{"period":"1month","weight":-0.1442},{"period":"3month","weight":-0.0729},{"period":"6month","weight":0},{"period":"1year","weight":-0.1359},{"period":"ytd","weight":-0.1909}],"compareEarnings":[{"period":"1week","weight":0.0133},{"period":"1month","weight":0.02},{"period":"3month","weight":0.0471},{"period":"6month","weight":0.0696},{"period":"1year","weight":0.217},{"period":"ytd","weight":0.0222}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Dimerix Limited, a clinical stage biotechnology company, develops and commercializes new therapies in the area of unmet medical needs. Its lead product candidate is DMX-200, which is in Phase II clinical trial for the treatment of diabetic kidney diseases and focal segmental glomerulosclerosis. The company is headquartered in Fitzroy, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.181818,"avgChangeRate":-0.098331},{"month":2,"riseRate":0.5,"avgChangeRate":0.059355},{"month":3,"riseRate":0.4,"avgChangeRate":0.044676},{"month":4,"riseRate":0.3,"avgChangeRate":0.035547},{"month":5,"riseRate":0.5,"avgChangeRate":0.05},{"month":6,"riseRate":0.8,"avgChangeRate":0.163438},{"month":7,"riseRate":0.272727,"avgChangeRate":0.065367},{"month":8,"riseRate":0.363636,"avgChangeRate":-0.063764},{"month":9,"riseRate":0.363636,"avgChangeRate":0.171129},{"month":10,"riseRate":0.181818,"avgChangeRate":-0.090222},{"month":11,"riseRate":0.272727,"avgChangeRate":0.028595},{"month":12,"riseRate":0.454545,"avgChangeRate":0.04297}],"exchange":"ASX","name":"DIMERIX LTD","nameEN":"DIMERIX LTD"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"DXB.AU\",market:\"AU\",,,undefined,":null}}